Compensation for Vaccine Side Effects: AIIMS Director Guleria

- Shashi Tharoor questioned whether Kovishield and Koleksin were allowed for emergency use

New delhi date. Sunday, January 3, 2021

The Serum Institute in India and Bharat Biotech's Corona vaccine Covishield and Colexin have been approved for emergency use by the Drugs Control General of India (DCGI). In response to the questions that are being raised about this approval, the director of AIIMS, Dr. Randeep Guleria has made an important statement. He said the person who would be vaccinated with the corona vaccine and have side effects would be compensated. The same was done during the clinical trial of this vaccine.

Congress leader Shashi Tharoor has questioned the emergency clearance given to the two vaccines. Shashi Tharoor said that in the event that the third phase trial of Covexin of Bharat Biotech has not yet taken place, it could be dangerous to approve it ahead of time. He called on Health Minister Dr. Harshvardhan has sought clarification. At the same time, Shashi Tharoor has said that India should use the estrogen vaccine.

Guillaria, director of the AIIMS, said the coxsackie would be used as a backup only if it came up with serious consequences for the new sultan of the corona virus from Britain. And if anyone has side effects after taking this vaccine, they will be compensated. "Safety is paramount whenever we talk about a vaccine," he added. For which the vaccine undergoes various stages, which may ensure its safety.

"Today is a very good day for our country," Guleria said. The beginning of the new year cannot be better than this. The two vaccines that are approved today are both made in India and easy to maintain.